Concepedia

Edward Hsiao

EH

Statistics

Publications

41

Citations

5.2K

H-Index

24

Active since

2004

Affiliations

Royal North Shore Hospital(Current)

The University of Sydney

Peter MacCallum Cancer Centre

Chris O’Brien Lifehouse

The University of Melbourne

Edward Hsiao is an author at Royal North Shore Hospital specializing in medicine, diagnostic imaging, and oncology.

Publications per year

2004–2025

41

Publications

41

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis et al. · The Lancet · 2020 · 2K citations

Medicine, Nuclear Medicine, Oncology +17

[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

Michael S. Hofman, Louise Emmett, Shahneen Sandhu et al. · The Lancet · 2021 · 1.1K citations

Medicine, Oncology, Pharmacology +12

The Impact of <sup>68</sup>Ga-PSMA PET/CT on Management Intent in Prostate Cancer: Results of an Australian Prospective Multicenter Study

Paul Roach, Roslyn J. Francis, Louise Emmett et al. · Journal of Nuclear Medicine · 2017 · 365 citations · Full text

Medicine, Oncology, Radiology +17

Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance

David LH Chan, Nick Pavlakis, Geoffrey Schembri et al. · Theranostics · 2017 · 286 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial

Michael S. Hofman, Louise Emmett, Shahneen Sandhu et al. · The Lancet Oncology · 2023 · 199 citations

Medicine, Oncology, Pharmacology +16

1–5 of 41